TAILIEUCHUNG - Chapter 042. Gastrointestinal Bleeding (Part 2)

Peptic Ulcers In addition to clinical features, characteristics of an ulcer at endoscopy provide important prognostic information. One-third of patients with active bleeding or a nonbleeding visible vessel have further bleeding that requires urgent surgery if they are treated conservatively. These patients clearly benefit from endoscopic therapy with bipolar electrocoagulation, heater probe, injection therapy (., absolute alcohol, 1:10,000 epinephrine), and/or clips with reductions in bleeding, hospital stay, mortality rate, and costs. In contrast, patients with clean-based ulcers have rates of recurrent bleeding approaching zero. If there is no other reason for hospitalization, such patients may be discharged on the. | Chapter 042. Gastrointestinal Bleeding Part 2 Peptic Ulcers In addition to clinical features characteristics of an ulcer at endoscopy provide important prognostic information. One-third of patients with active bleeding or a nonbleeding visible vessel have further bleeding that requires urgent surgery if they are treated conservatively. These patients clearly benefit from endoscopic therapy with bipolar electrocoagulation heater probe injection therapy . absolute alcohol 1 10 000 epinephrine and or clips with reductions in bleeding hospital stay mortality rate and costs. In contrast patients with clean-based ulcers have rates of recurrent bleeding approaching zero. If there is no other reason for hospitalization such patients may be discharged on the first hospital day following stabilization. Patients without clean-based ulcers should usually remain in the hospital for 3 days as most episodes of recurrent bleeding occur within 3 days. Randomized controlled trials document that a high-dose constant-infusion IV proton pump inhibitor PPI . omeprazole 80-mg bolus and 8-mg h infusion designed to sustain intragastric pH 6 and enhance clot stability decreases further bleeding but not mortality in patients with high-risk ulcers active bleeding nonbleeding visible vessel adherent clot even after appropriate endoscopic therapy. Institution of therapy at presentation in all patients with UGIB does not significantly improve outcomes such as further bleeding transfusions or mortality as compared to initiating therapy only when high-risk ulcers are identified at the time of endoscopy. One-third of patients with a bleeding ulcer will rebleed within the next 1-2 years. Prevention of recurrent bleeding focuses on the three main factors in ulcer pathogenesis H. pylori NSAIDs and acid. Eradication of H. pylori in patients with bleeding ulcers decreases rates of rebleeding to 5 . If a bleeding ulcer develops in a patient taking NSAIDs the NSAIDs should be discontinued if .

TỪ KHÓA LIÊN QUAN
TAILIEUCHUNG - Chia sẻ tài liệu không giới hạn
Địa chỉ : 444 Hoang Hoa Tham, Hanoi, Viet Nam
Website : tailieuchung.com
Email : tailieuchung20@gmail.com
Tailieuchung.com là thư viện tài liệu trực tuyến, nơi chia sẽ trao đổi hàng triệu tài liệu như luận văn đồ án, sách, giáo trình, đề thi.
Chúng tôi không chịu trách nhiệm liên quan đến các vấn đề bản quyền nội dung tài liệu được thành viên tự nguyện đăng tải lên, nếu phát hiện thấy tài liệu xấu hoặc tài liệu có bản quyền xin hãy email cho chúng tôi.
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.